Figure 2
Figure 2. (A-C) Cumulative incidences of grade II-IV acute GVHD at day +100 (A), neutrophil recovery ≥500/μL by day +42 (B), and platelet recovery ≥20 000/μL at day +180 (C) for Treg recipients (solid line) and Siro/MMF controls (dotted line). (D) The density of infections at day +100 in Treg recipients (▪) and Siro/MMF controls (□).

(A-C) Cumulative incidences of grade II-IV acute GVHD at day +100 (A), neutrophil recovery ≥500/μL by day +42 (B), and platelet recovery ≥20 000/μL at day +180 (C) for Treg recipients (solid line) and Siro/MMF controls (dotted line). (D) The density of infections at day +100 in Treg recipients (▪) and Siro/MMF controls (□).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal